Diagnostic accuracy of a 2D left ventricle hypertrophy score for familial hypertrophic cardiomyopathy

European Heart Journal

Volumn 26, Issue 18, 2005, Pages 1882-1886

  Forissier, Jean F ^a   Charron, Philippe ^b,e   Du Montcel, Sophie Tezenas ^b   Hagège, Albert ^c,e   Isnard, Richard ^b,e   Carrier, Lucie ^b   Richard, Pascale ^b,e   Desnos, Michel ^c,e   Bouhour, Jean B ^d   Schwartz, Ketty ^b   Komajda, Michel ^b,e   Dubourg, Olivier ^a,e  

^a HÔPITAL AMBROISE PARÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d CHU de Nantes   (France)

^e Centre de Référence Maladies Cardiaques Héré ditaires   (France)

Author keywords

Diagnosis; Echocardiography; Gene; Hypertrophic cardiomyopathy; Left ventricular mass

Indexed keywords

ADULT; ARTICLE; BODY SURFACE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ECHOCARDIOGRAPHY; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FEMALE; GENOTYPE; HEART VENTRICLE HYPERTROPHY; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 24344479636     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi276     Document Type: Article

References (28)

1. Report of the 1995 World Health Organisation/International Society and Federation of cardiology task force on the definition and classification of Cardiomyopathies. Circulation 1996;93:841-842.
2. Maron BJ. Hypertrophic cardiomyopathy, a systematic review. JAMA 2002;287:1308-1320.
3. Maron BJ. Sudden death in young athletes. N Engl J Med 2003;349:1064-1075.
4. Charron P, Dubourg O, Desnos M, Isnard R, Hagège A, Millaire A, Carrier L, Bonne G, Tesson F, Richard P, Bouhour JB, Schwartz K, Komajda M. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 1997;96:214-219.
5. Reichek N, Helak J, Plappert T, St John Sutton M, Weber K. Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results. Circulation 1983;67:348-352.
6. Spirito P, Maron BJ. Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1987;9:1013-1017.
7. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990;15:1521-1526.
8. Posma JL, Blanksma PK, Van der Wall EE, Hamer HP, Mooyaart EL, Lie KI. Assessment of quantitative hypertrophy scores in hypertrophic cardiomyopathy: magnetic resonance imaging versus echocardiography. Am Heart J 1996;132:1020-1027.
9. Pons-Llado G, Carreras F, Borras X, Palmer J, Llauger J, Bayes de Luna A. Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echographic imaging. Am J Cardiol 1997;79:1651-1656.
10. Flavigny J, Richard P, Isnard R, Carrier L, Charron P, Bonne G, Forissier JF, Desnos M, Dubourg O, Komajda M, Schwartz K, Hainque B. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. J Mol Med 1998;76:208-214.
11. Forissier JF, Carrier L, Farza H, Bonne G, Bercovici J, Richard P, Hainque B, Townsend PJ, Yacoub MH, Faure S, Dubourg O, Millaire A, Hagège A, Desnos M, Komajda M, Schwartz K. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation 1996;94:3069-3073.
12. Richard P, Charron P, Carrier L, Ledeuil C. Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations and implications for a molecular diagnosis strategy. Circulation 2003;107:2227-2232.
13. Dubourg O, Isnard R, Hagege A, Jondeau G, Desnos M, Sacrez A, Bouhour JB, Messner-Pellenc P, Millaire A, Fetler L. Doppler echocardiography in familial hypertrophic cardiomyopathy: the French cooperative study. Echocardiography 1995;12:235-241.
14. Gardin JM, Savage DD, Ware JH, Henry W.L. Effect of age, sex, and body surface area on echocardiographic left ventricular wall mass in normal subjects. Hypertension 1987;9(Suppl. II):II36-II39.
15. Mousseaux E, Beygui F, Fornès P, Chatellier G, Hagège A, Desnos M, Lecomte D, Gaux JC. Determination of left ventricular mass with electron beam computed tomography in deformed, hypertrophic human hearts. Eur Heart J 1994;15:832-841.
16. Higgins CB, Byrd BF, Stark D, Mc Namara M, Lanzer P, Lipton MJ, Schiller NB, Botvinick E, Chatterjee K. Magnetic resonance imaging in hypertrophic cardiomyopathy. Am J Cardiol 1985;55:1121-1126.
17. Been N, Kean D, Smith MA, Douglas RHB, Best JJK, Muir AL. Nuclear magnetic resonance in hypertrophic cardiomyopathy. Br Heart J 1985;54:48-52.
18. Suzuki J, Watanabe F, Takenaka K et al. New subtype of apical hypertrophic cardiomyopathy identified with nuclear magnetic resonance imaging as an underlying cause of markedly inverted T waves. J Am Coll Cardiol 1993;22:1175-1181.
19. Charron P, Carrier L, Dubourg O, Tesson F, Desnos M, Richard P, Bonne G, Guicheney P, Hainque B, Bouhour JB, Mallet A, Feingold J, Schwartz K, Komajda M. Penetrance of familial hypertrophic cardiomyopathy. Genet Couns 1997;8:107-114.
20. Devereux RB, Casale PN, Kligfield P et al. Performance of primary derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy. Am J Cardiol 1986;57:1388-1393.
21. Charron P, Heron D, Gargiulo M, Richard P, Dubourg O, Desnos M, Bouhour JB, Feingold J, Carrier L, Hainque B, Schwartz K, Komajda M. Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience. J Med Genet 2002;39:741-746.
22. Charron P, Forissier JF, Amara ME, Dubourg O, Desnos M, Bouhour JB, Isnard R, Hagège A, Benaiche A, Richard P, Schwartz K, Komajda M. Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population. Int J Cardiol 2003;90:33-40.
23. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. Eur Heart J 2003;24:1965-1991.
24. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 2001;33:655-670.
25. Geisterfer-Lowrance A, Christe M, Conner D, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science 1996;272:731-734.
26. Nageh S, Bachinski L, Meyer D, Hill R, Zoghbi WA, Tam JW, Quinones MA, Roberts R, Marian AJ. Tissue Doppler imaging detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001;104:128-130.
27. Nagueh SF, McFalls J, Meyer D, Hill R, Zoghbi WA, Tam JW, Quinones MA, Roberts R, Marian AJ. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation 2003;108:395-398.
28. Ho C, Sweitzer N, McDonough B, Maron BJ, Casey SA, Seidman JG, Seidman CE, Solomon SD. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 2002;105:2992-2997.